344 results on '"Schally, Andrew V."'
Search Results
2. Agonist of growth hormone–releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
3. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction
4. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target
5. Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation
6. Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis
7. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
8. Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress
9. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH
10. Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth
11. Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy
12. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure
13. The Expression of the Pituitary Growth Hormone-Releasing Hormone Receptor and Its Splice Variants in Normal and Neoplastic Human Tissues
14. Antagonists of Growth Hormone-Releasing Hormone Cross the Blood-Brain Barrier: A Potential Applicability to Treatment of Brain Tumors
15. Effective Treatment of Experimental Human Non-Hodgkin's Lymphomas with Antagonists of Growth Hormone-Releasing Hormone
16. Antagonist of Growth Hormone-Releasing Hormone Induces Apoptosis in LNCaP Human Prostate Cancer Cells through a Ca 2+ -Dependent Pathway
17. Development of a Polyclonal Antiserum for the Detection of the Isoforms of the Receptors for Human Growth Hormone-Releasing Hormone on Tumors
18. Effect of Long-Term Treatment with Low Doses of the LHRH Antagonist Cetrorelix on Pituitary Receptors for LHRH and Gonadal Axis in Male and Female Rats
19. A Pituitary Gene Encodes a Protein That Produces Differentiation of Breast and Prostate Cancer Cells
20. Increased Activity of Antagonists of Growth Hormone-Releasing Hormone Substituted at Positions 8, 9, and 10
21. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
22. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells
23. Inhibition of Mutant p53 Expression and Growth of DMS-153 Small Cell Lung Carcinoma by Antagonists of Growth Hormone-Releasing Hormone and Bombesin
24. Ligand-Dependent and -Independent Effects of Splice Variant 1 of Growth Hormone-Releasing Hormone Receptor
25. Growth Hormone-Releasing Hormone (GHRH) Antagonists Inhibit the Proliferation of Androgen-Dependent and -Independent Prostate Cancers
26. Somatostatin Receptor Subtype 2 Sensitizes Human Pancreatic Cancer Cells to Death Ligand-Induced Apoptosis
27. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling
28. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells
29. Effects of Long-Term Treatment with the Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Decapeptyl and the LHRH Antagonist Cetrorelix on the Levels of Pituitary LHRH Receptors and Their mRNA Expression in Rats
30. The Expression of Growth Hormone-Releasing Hormone (GHRH) and Splice Variants of Its Receptor in Human Gastroenteropancreatic Carcinomas
31. Bombesin Antagonists Inhibit Growth of MDA-MB-435 Estrogen-Independent Breast Cancers and Decrease the Expression of the ErbB-2/HER-2 Oncoprotein and c-jun and c-fos Oncogenes
32. Changes in Subcellular Distribution of Pituitary Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) after Treatment with the LH-RH Antagonist Cetrorelix
33. Expression of a Splice Variant of the Receptor for GHRH in 3T3 Fibroblasts Activates Cell Proliferation Responses to GHRH Analogs
34. Comparison of Mechanisms of Action of Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist Cetrorelix and LHRH Agonist Triptorelin on the Gene Expression of Pituitary LHRH Receptors in Rats
35. Luteinizing Hormone-Releasing Hormone (LH-RH) Antagonist Cetrorelix Down-Regulates the mRNA Expression of Pituitary Receptors for LH-RH by Counteracting the Stimulatory Effect of Endogenous LH-RH
36. Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
37. Isolation and Sequencing of cDNAs for Splice Variants of Growth Hormone-Releasing Hormone Receptors from Human Cancers
38. Human Renal Cell Carcinoma Expresses Distinct Binding Sites for Growth Hormone-Releasing Hormone
39. Inhibition of Growth and Metastatic Progression of Pancreatic Carcinoma in Hamster after Somatostatin Receptor Subtype 2 (sst2) Gene Expression and Administration of Cytotoxic Somatostatin Analog AN-238
40. Antagonistic Actions of Analogs Related to Growth Hormone-Releasing Hormone (GHRH) on Receptors for GHRH and Vasoactive Intestinal Peptide on Rat Pituitary and Pineal Cells in vitro
41. Stability of Cytotoxic Luteinizing Hormone-Releasing Hormone Conjugate (AN-152) Containing Doxorubicin 14-O-Hemiglutarate in Mouse and Human Serum in vitro: Implications for the Design of Preclinical Studies
42. Inhibition of Growth, Production of Insulin-Like Growth Factor-II (IGF-II), and Expression of IGF-II mRNA of Human Cancer Cell Lines by Antagonistic Analogs of Growth Hormone-Releasing Hormone in vitro
43. Selective Induction of Apoptosis by the Cytotoxic Analog AN-207 in Cells Expressing Recombinant Receptor for Luteinizing Hormone-Releasing Hormone
44. Synthesis and Biological Evaluation of Antagonists of Growth Hormone-Releasing Hormone with High and Protracted in vivo Activities
45. Decrease in Telomerase Activity in U-87MG Human Glioblastomas after Treatment with an Antagonist of Growth Hormone-Releasing Hormone
46. Growth Hormone-Releasing Hormone Antagonist MZ-5-156 Inhibits Growth of DU-145 Human Androgen-Independent Prostate Carcinoma in Nude Mice and Suppresses the Levels and mRNA Expression of Insulin-Like Growth Factor II in tumors
47. Synthesis and Biological Evaluation of Cytotoxic Analogs of Somatostatin Containing Doxorubicin or Its Intensely Potent Derivative, 2-pyrrolinodoxorubicin
48. A Single in vivo Administration of Bombesin Antagonist RC-3095 Reduces the Levels and mRNA Expression of Epidermal Growth Factor Receptors in MXT Mouse Mammary Cancers
49. Characterization of the Antiproliferative Signal Mediated by the Somatostatin Receptor Subtype sst5
50. Growth Hormone-Releasing Hormone Antagonist MZ-4-71 Inhibits in vivo Proliferation of Caki-i Renal Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.